BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11360146)

  • 1. Impaired fasting glycaemia in middle-aged women: a prospective study.
    Guthrie JR; Ball M; Dudley EC; Garamszegi CV; Wahlqvist ML; Dennerstein L; Burger HG
    Int J Obes Relat Metab Disord; 2001 May; 25(5):646-51. PubMed ID: 11360146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
    Lee CJ; Lim NK; Kim HC; Ihm SH; Lee HY; Park HY; Park S
    Am J Hypertens; 2015 Apr; 28(4):493-500. PubMed ID: 25267735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population.
    Qian Y; Lin Y; Zhang T; Bai J; Chen F; Zhang Y; Luo S; Shen H
    BMC Public Health; 2010 Mar; 10():139. PubMed ID: 20233452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density in diabetes and impaired fasting glucose.
    Holloway-Kew KL; Marijanovic N; De Abreu LLF; Sajjad MA; Pasco JA; Kotowicz MA
    Osteoporos Int; 2019 Sep; 30(9):1799-1806. PubMed ID: 31367948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHBG levels correlate with insulin resistance in postmenopausal women.
    Akin F; Bastemir M; Alkiş E; Kaptanoglu B
    Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of sex hormone-binding globulin, corticosteroid-binding globulin and cortisol in overweight subjects who develop impaired fasting glucose: a 3-year prospective study.
    Lewis JG; Shand BI; Frampton CM; Elder PA; Scott RS
    Horm Metab Res; 2009 Mar; 41(3):255-9. PubMed ID: 18949680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of pregnancy outcomes and risk of LGA neonates in Caucasian females according to IADPSG criteria for gestational diabetes mellitus.
    Disse E; Graeppi-Dulac J; Joncour-Mills G; Dupuis O; Thivolet C
    Diabetes Metab; 2013 Apr; 39(2):132-8. PubMed ID: 23182459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands.
    de León AC; Coello SD; González DA; Díaz BB; Rodríguez JC; Hernández AG; Aguirre-Jaime A; Pérez Mdel C
    Diabet Med; 2012 Mar; 29(3):399-403. PubMed ID: 21883429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma insulin levels in an unselected Prague suburban population.
    Andĕl M; Kraml P; Málková J; Procházková Z; Poledne R; Potocková J
    Cent Eur J Public Health; 1998 Feb; 6(1):4-9. PubMed ID: 9524734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance.
    Lemay A; Turcot L; Déchêne F; Dodin S; Forest JC
    Menopause; 2010 Mar; 17(2):321-5. PubMed ID: 19745772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of menopausal status on onset of impaired fasting glucose and type 2 diabetes mellitus].
    Wen JB; Yang S; Zhao XH; Chen YC; Zhao HL; Chen XT; Shen C
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):728-733. PubMed ID: 28763923
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese.
    Chen LK; Lin MH; Chen ZJ; Hwang SJ; Tsai ST; Chiou ST
    Diabetes Res Clin Pract; 2006 Feb; 71(2):170-6. PubMed ID: 16026886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database.
    Sesti G; Andreozzi F; Bonadonna RC; De Mattia G; Leonetti F; Luzi L; Marini MA; Natali A; Vettor R; Bonora E;
    Diabetes Metab Res Rev; 2008 Feb; 24(2):130-6. PubMed ID: 17922529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany.
    Wabitsch M; Hauner H; Hertrampf M; Muche R; Hay B; Mayer H; Kratzer W; Debatin KM; Heinze E
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):307-13. PubMed ID: 14724655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study.
    Guerrero-Romero F; Rodríguez-Morán M; Pérez-Fuentes R; Sánchez-Guillén MC; González-Ortiz M; Martínez-Abundis E; Brito-Zurita O; Madero A; Figueroa B; Revilla-Monsalve C; Flores-Martínez SE; Islas-Andrade S; Rascón-Pacheco RA; Cruz M; Sánchez-Corona J
    Metab Syndr Relat Disord; 2008 Mar; 6(1):15-23. PubMed ID: 18370832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.